The Personalised Cancer Medicine Program at Karolinska Institutet

The Personalised Cancer Medicine Program at Karolinska Institutet (KIPCM) is a research initiative with the primary task to strengthen the infrastructure for team science addressing PCM.

The foundation of the activities is to create a strong network, especially between KI, Karolinska University Hospital (K) and Science for Life Laboratory (SciLifeLab), to facilitate the development of PCM as a leading treatment concept in academic cancer healthcare in Stockholm. It also serves the local contact point for collaborations with major cancer centers in Europe within the organization Cancer Core Europe.


Action points:

  • to enhance the local machinery for early clinical trials (phase 0-II)
  • to optimize the collaboration with Cancer Core Europe (CCE)
  • to support the development of bioinformatics support and clinical decision tools
  • to find solutions for local, national and international data-sharing
  • to exploit modern diagnostic imaging technologies for PCM-research
  • to involve patient representatives and utilize patient self-reported data


The Karolinska PCM program website


The PCM Program is generously supported by The Cancer Research Funds of Radiumhemmet.


Content reviewer:
Dina Dabaghie